Allogeneic Cell Therapy Market

Global Allogeneic Cell Therapy Market Size, Trends & Analysis - Forecasts to 2027 By Type (T-Cell Therapy, Stem Cell Therapy, Others), By Indication (Cancer, Musculoskeletal Disorders (MSD), Cardiovascular Diseases, Others), By End-User (Hospitals & Clinics, Biotechnology & Pharmaceutical Companies, Research Institutes), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis

Category Healthcare

Format

This report was recently updated on July 20 2024 with the latest and most recent market numbers

Global Allogeneic Cell Therapy Market Size

The global allogeneic cell therapy market is projected to grow from USD 994.9 million in 2022 to USD 1,570.1 million in 2027 at a CAGR of 9.6% from 2022 to 2027.

Allogeneic cell treatment market growth is being fueled by factors like increasing stem cell research initiatives and rising permits for GMP-certified facilities to conduct stem cell research and therapies. Demand for allogeneic cell therapy, stem cell therapy sales, research activity, and funding for cell-based research has increased as a result of the need for new and improved treatments for immunological, neurodegenerative, and myocardial infarctions.

Greater unrealized demands for the management of chronic diseases and increased funding for stem cell and T cell research are the main factors driving the global market for allogeneic stem cell therapy.

Various pharmaceutical companies are now developing a variety of tissue-engineered products as well as autologous and allogeneic cell therapies.

The need for cell and gene therapies as well as the growing need for induced pluripotent stem cells as an alternative to embryonic stem cells are likely to drive growth in the market for allogeneic cell therapy. People are becoming more aware of cancer and the latest cutting-edge cell treatments offered today as cancer has become one of the main causes of mortality around the globe.

In the United States, 1,752,735 new cases of cancer were reported in 2019, while 599,589 people passed away from the disease. 439 new cases of cancer and 146 cancer-related deaths were reported for every 100,000 persons. In the United States, there are anticipated to be 1,918,030 new cancer cases and 609,360 cancer deaths in 2022, with lung cancer as the primary cause of death accounting for about 350 of those fatalities daily.

The increasing focus on gene therapy-based therapies for cancer treatment by pharmaceutical companies and the increasing number of government initiatives for supplementing research are expected to contribute to the rapid growth of the allogeneic cell therapy market.

The market for allogeneic cell therapies is expected to grow during the forecast period due to the rising use of T-cell therapy for COVID-19 patient care. In 2021, GIOSTAR received FDA authorization to offer COVID patients stem cell therapy. Demand for cell treatment for COVID increased marginally as a result of its use.

Engineered T cells are modified T cells that have been specially formulated to cure cancer. These cells, which comprise tumor invasive lymphocytes, T cell receptors (TCR), and antigen receptors, are currently employed for medicinal and exploratory purposes. Additionally, modified T cells are utilized to treat different tumors and get beyond immune-suppressive tumor cells, which prevent T cells from recognizing tumor cells as alien objects. They are also the modified T cells that work to lessen side effects and prevent antigen egress for treatment applications.

The allogeneic cell therapy business is constrained by ethical issues related to stem cells and T-cell therapies. The need for stem cell therapy raises various ethical questions because human embryos must be killed in order to obtain stem cells. It is morally immoral to kill a human embryo since they are viewed as potential life, even if doing so might save a human life. Concerns regarding using ESCs to build allogeneic cell treatments are limiting the growth of the allogeneic cell therapy business and the sales of allogeneic cell medicines.

global allogeneic cell therapy market

COVID-19 Impact on Global Allogeneic Cell Therapy Market

The COVID-19 epidemic has increased sales for a number of pharmaceutical and biotechnology firms. The outbreak has caused the healthcare sector as a whole to grow significantly, albeit other areas, including oncology, have had to take a backseat as the globe focuses on reducing the pandemic's effects. Pharmaceutical and biotechnology businesses are anticipated to expand their investment in the development of cutting-edge cancer medicines and diagnostics as more money becomes available as the world begins to return to normal.

Increasing investment in vaccine development and novel therapeutic methods have increased the demand for the application of stem cells, gene therapy, and T cell-based treatments for COVID-19 applications are expected to result in the rapid growth of the allogeneic cell therapy market.

Global Allogeneic Cell Therapy Market: By Type

The stem cell therapy segment is expected to be the largest allogeneic cell therapy market segment based on the type. The growing number of FDA approvals and increasing investments in stem cell research have led the stem cell therapy segment to hold the dominant share of the market.

The T-cell therapy segment is expected to be the fastest-growing segment in the market. The growing expenditure on T-cell therapies for COVID-19 applications and growing demand for T-cell cell treatments for cardiovascular and musculoskeletal disorder treatments are expected to result in the rapid growth of the T-cell therapy segment.

Global Allogeneic Cell Therapy Market: By Indication

The cancer segment is expected to be the largest allogeneic cell therapy market segment based on the indication. The growing mortality rate of cancer, the increasing geriatric population, and the rising investment in allogeneic stem cell research from cancer foundations and government organizations have led to the large share of the cancer segment.

The musculoskeletal disorders (MSD) segment is expected to be the fastest-growing segment in the market. The rising geriatric population in developing nations, increasing expenditure on musculoskeletal disorder treatments, and the increasing number of innovative treatments that are becoming available in recent years are expected to lead to the rapid growth of the musculoskeletal disorders segment.

Global Allogeneic Cell Therapy Market: By End-User

The biotechnology & pharmaceutical companies segment is expected to be the largest allogeneic cell therapy market segment based on the end-users. Heavy investment in allogeneic cell research and product approvals by pharmaceutical and biotechnology companies combined with the rapid advancements in technology have led to this segment holding the largest share of the market, based on end-users.

The research institutes segment is expected to be the fastest-growing segment in the market. The growing number of collaborations between government organizations and private companies with research institutes is a major driver of this segment. The growing amount of research output from world-class research institutes and the growing focus on T-cell and stem cell research are also expected to result in the rapid advancement of the research institutes segment.

asia pacific allogeneic cell therapy market

Global Allogeneic Cell Therapy Market: By Region

Growing investment in the cell, gene, and tissue therapies has been a key factor in the market's growth in North America.

The North American allogeneic cell therapy market is anticipated to be dominated by the United States. The demand for advanced therapy pharmaceuticals is anticipated to rise as a result of the increasing number of FDA approvals for gene therapy and stem cell therapy treatment methods.

However, throughout the projected period, the Asia-Pacific region is anticipated to exhibit the market's fastest growth. A significant factor in the expansion of the market in the APAC region has been the region's expanding pharmaceutical manufacturing sector, which has been combined with increased investments in cell treatment in the region.

The Asia Pacific allogeneic cell therapy market is anticipated to be dominated by China. The need for cell therapy for cardiovascular disease treatment, cancer therapeutics, and other chronic disorders in China is anticipated to rise as the nation invests more money in the creation of breakthrough medical treatments and pharmaceuticals.

Global Allogeneic Cell Therapy Market Share and Competitor Analysis

Allogene Therapeutics, Century Therapeutics, Bristol Myers Squibb, Adaptimmune Ltd, Autolus., TrakCel, Tmunity Therapeutics, Bellicum Pharmaceuticals Inc., Sorrento Therapeutics, Bluebird Inc., Minerva Biotechnologies Corporation, Kite Pharma, Celgene Corporation, Cellectis, Fortress Biotech., Promab Biotechnologies, Immune Therapeutics, Ziopharm Oncology Inc., Juno Therapeutics, Novartis AG, Celyad, Eureka Therapeutics Inc., TILT Biotherapeutics, and Poseida Therapeutics Inc., among others, are some of the key players in the allogeneic cell therapy market.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1 Research Methodology

1.1 Research Assumptions

1.2 Research Methodology

1.2.1 Estimates and Forecast Timeline

1.3 Information Procurement

1.3.1 Purchased Database

1.3.2 GME’s Internal Database

1.3.3 Primary Research

1.3.4 Secondary Sources & Third-Party Perspectives

1.3.4.1 Company Information Sources

1.3.4.2 Secondary Data Sources

1.4 Information or Data Analysis

1.4.1 Data Analysis Models

1.5 Market Formulation & Data Visualization

1.6 Data Validation & Publishing

1.7 Market Model

1.7.1 Model Details

1.7.1.1 Top-Down Approach

1.7.1.2 Bottom-Up Approach

1.8 Market Segmentation & Scope

1.9 Market Definition

Chapter 2 Executive Summary

2.1 Global Market Outlook

2.2 Indication Outlook

2.3 Type Outlook

2.4 End-User Outlook

2.5 Regional Outlook

Chapter 3 Global Allogeneic Cell Therapy Market Trend Analysis

3.1. Market Introduction

3.2 Penetration & Growth Prospect Mapping

3.3 Impact of COVID-19 on the Allogeneic Cell Therapy Market

3.4 Metric Data based on the industry

3.5 Market Dynamic Analysis

3.5.1 Market Driver Analysis

3.5.2 Market Restraint Analysis

3.5.3 Industry Challenges

3.5.4 Industry Opportunities

3.6 Porter’s Five Analysis

3.6.1 Supplier Power

3.6.2 Buyer Power

3.6.3 Substitution Threat

3.6.4 Threat from New Entrant

3.7 Market Entry Strategies

Chapter 4 Allogeneic Cell Therapy Market: By Indication Trend Analysis

4.1 By Indication: Historic Data vs. Forecast Data Analysis, 2021 vs. 2027

4.2 Cancer

4.2.1 Market Estimates & Forecast Analysis of Cancer Segment, By Region, 2019-2027 (USD Million)

4.3 Musculoskeletal Disorders (MSD)

4.3.1 Market Estimates & Forecast Analysis of Musculoskeletal Disorders (MSD) Segment, By Region, 2019-2027 (USD Million)

4.4 Cardiovascular Diseases

4.4.1 Market Estimates & Forecast Analysis of Cardiovascular Diseases Segment, By Region, 2019-2027 (USD Million)

4.5 Others

4.5.1 Market Estimates & Forecast Analysis of Others Segment, By Region, 2019-2027 (USD Million)

Chapter 5 Allogeneic Cell Therapy Market: By End-User Trend Analysis

5.1 By End-User: Historic Data vs. Forecast Data Analysis, 2021 vs. 2027

5.2 Hospitals & Clinics

5.2.1 Market Estimates & Forecast Analysis of Hospitals & Clinics, By Region, 2019-2027 (USD Million)

5.3 Biotechnology & Pharmaceutical Companies

5.3.1 Market Estimates & Forecast Analysis of Biotechnology & Pharmaceutical Companies Market Segment, By Region, 2019-2027 (USD Million)

5.4 Research Institutes

5.4.1 Market Estimates & Forecast Analysis of Research Institutes Segment, By Region, 2019-2027 (USD Million)

Chapter 6 Allogeneic Cell Therapy Market: By Type Trend Analysis

6.1 By Type: Historic Data vs. Forecast Data Analysis, 2022 vs. 2027

6.2 T-cell Therapies

6.2.1 Market Estimates & Forecast Analysis of T-cell Therapies Segment, By Region, 2019-2027 (USD Million)

6.3 Stem Cell Therapies

6.3.1 Market Estimates & Forecast Analysis of Stem Cell Therapies Segment, By Region, 2019-2027 (USD Million)

6.4 Others

6.4.1 Market Estimates & Forecast Analysis of Others Segment, By Region, 2019-2027 (USD Million)

Chapter 7 Allogeneic Cell Therapy Market, By Region

7.1 Regional Outlook

7.2 North America

7.2.1 Market Estimates & Forecast Analysis, By Country 2019-2027 (USD Million)

7.2.2 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.2.3 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.2.4 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.2.5 U.S.

7.2.5.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.2.5.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.2.5.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.2.6 Canada

7.2.6.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.2.6.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.2.6.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.5.7 Mexico

7.5.5.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.5.5.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.5.5.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.3 Europe

7.3.1 Market Estimates & Forecast Analysis, By Country 2019-2027 (USD Million)

7.3.2 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.3.3 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.3.4 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.3.5 Germany

7.3.5.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.3.5.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.3.5.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.3.6 UK

7.3.6.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.3.6.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.3.6.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.3.7 France

7.3.7.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.3.7.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.3.7.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.3.8 Russia

7.3.8.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.3.8.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.3.8.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.3.9 Italy

7.3.9.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.3.9.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.3.9.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.3.10 Spain

7.3.10.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.3.10.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.3.10.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.3.11 Netherlands

7.3.11.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.3.11.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.3.11.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.3.12 Rest of Europe

7.3.12.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.3.12.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.3.12.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.4 Asia Pacific

7.4.1 Market Estimates & Forecast Analysis, By Country 2019-2027 (USD Million)

7.4.2 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.4.3 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.4.4 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.4.5 China

7.4.5.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.4.5.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.4.5.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.4.6 India

7.4.6.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.4.6.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.4.6.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.4.7 Japan

7.4.7.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.4.7.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.4.7.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.4.8 South Korea

7.4.8.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.4.8.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.4.8.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.4.9 Thailand

7.4.9.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.4.9.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.4.9.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.4.10 Indonesia

7.4.10.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.4.10.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.4.10.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.4.11 Malaysia

7.4.11.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.4.11.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.4.11.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.4.12 Singapore

7.4.12.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.4.12.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.4.12.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.4.13 Vietnam

7.4.13.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.4.13.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.4.13.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.4.14 Rest of Asia Pacific

7.4.14.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.4.14.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.4.14.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.5 Central & South America

7.5.1 Market Estimates & Forecast Analysis, By Country 2019-2027 (USD Million)

7.5.2 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.5.3 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.5.4 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.5.5 Brazil

7.5.5.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.5.5.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.5.5.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.5.6 Argentina

7.5.6.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.5.6.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.5.6.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.5.7 Chile

7.5.7.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.5.7.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.5.7.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.5.8 Rest of Central & South America

7.5.8.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.5.8.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.5.8.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.6 Middle East & Africa

7.6.1 Market Estimates & Forecast Analysis, By Country 2019-2027 (USD Million)

7.6.2 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.6.3 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.6.4 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.6.5 Saudi Arabia

7.6.5.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.6.5.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.6.5.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.6.6 United Arab Emirates

7.6.6.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.6.6.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.6.6.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.6.7 South Africa

7.6.7.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.6.7.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.6.7.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.6.8 Israel

7.6.8.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.6.8.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.6.8.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

7.5.9 Rest of Middle East & Africa

7.5.9.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Million)

7.5.9.2 Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Million)

7.5.9.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Million)

Chapter 8 Competitive Analysis

8.1 Key Global Players, Recent Developments & their Impact on the Industry

8.2 Four Quadrant Competitor Positioning Matrix

8.2.1 Key Innovators

8.2.2 Market Leaders

8.2.3 Emerging Players

8.2.4 Market Challengers

8.3 Vendor Landscape Analysis

8.4 End-User Landscape Analysis

8.5 Company Market Share Analysis, 2021

Chapter 9 Company Profile Analysis

9.1 Allogene Therapeutics

9.1.1 Company Overview

9.1.2 Financial Analysis

9.1.3 Strategic Initiatives

9.1.4 Product Benchmarking

9.2 Century Therapeutics

9.2.1 Company Overview

9.2.2 Financial Analysis

9.2.3 Strategic Initiatives

9.2.4 Product Benchmarking

9.3 Bristol Myers Squibb

9.3.1 Company Overview

9.3.2 Financial Analysis

9.3.3 Strategic Initiatives

9.3.4 Product Benchmarking

9.4 Adaptimmune Ltd

9.4.1 Company Overview

9.4.2 Financial Analysis

9.4.3 Strategic Initiatives

9.4.4 Product Benchmarking

9.5 Autolus

9.5.1 Company Overview

9.5.2 Financial Analysis

9.5.3 Strategic Initiatives

9.5.4 Product Benchmarking

9.6 TrakCel

9.6.1 Company Overview

9.6.2 Financial Analysis

9.6.3 Strategic Initiatives

9.6.4 Product Benchmarking

9.7 Tmunity Therapeutics

9.7.1 Company Overview

9.7.2 Financial Analysis

9.7.3 Strategic Initiatives

9.7.4 Product Benchmarking

9.8 Bellicum Pharmaceuticals Inc.

9.8.1 Company Overview

9.8.2 Financial Analysis

9.8.3 Strategic Initiatives

9.8.4 Product Benchmarking

9.9 Sorrento Therapeutics

9.9.1 Company Overview

9.9.2 Financial Analysis

9.9.3 Strategic Initiatives

9.9.4 Product Benchmarking

9.10 Bluebird Inc.

9.10.1 Company Overview

9.10.2 Financial Analysis

9.10.3 Strategic Initiatives

9.10.4 Product Benchmarking

9.11 Other Companies

9.11.1 Company Overview

9.11.2 Financial Analysis

9.11.3 Strategic Initiatives

9.11.4 Product Benchmarking

List of Tables

1 Technological Advancements in Allogeneic Cell Therapy Market

2 Global Allogeneic Cell Therapy Market: Key Market Drivers

3 Global Allogeneic Cell Therapy Market: Key Market Challenges

4 Global Allogeneic Cell Therapy Market: Key Market Opportunities

5 Global Allogeneic Cell Therapy Market: Key Market Restraints

6 Global Allogeneic Cell Therapy Market Estimates & Forecast Analysis, 2019-2027 (USD Million)

7 Global Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

8 Cancer: Global Allogeneic Cell Therapy Market, By Region, 2019-2027 (USD Million)

9 Musculoskeletal disorders (MSD): Global Allogeneic Cell Therapy Market, By Region, 2019-2027 (USD Million)

10 Cardiovascular Diseases: Global Allogeneic Cell Therapy Market, By Region, 2019-2027 (USD Million)

11 Others: Global Allogeneic Cell Therapy Market, By Region, 2019-2027 (USD Million)

12 Global Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

13 Hospitals & Clinics: Global Allogeneic Cell Therapy Market, By Region, 2019-2027 (USD Million)

14 Research Institutes: Global Allogeneic Cell Therapy Market, By Region, 2019-2027 (USD Million)

15 Biotechnology & Pharmaceutical Companies: Global Allogeneic Cell Therapy Market, By Region, 2019-2027 (USD Million)

16 Global Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

17 T-cell Therapies: Global Allogeneic Cell Therapy Market, By Region, 2019-2027 (USD Million)

18 Stem Cell Therapies: Global Allogeneic Cell Therapy Market, By Region, 2019-2027 (USD Million)

19 Others: Global Allogeneic Cell Therapy Market, By Region, 2019-2027 (USD Million)

20 Regional Analysis: Global Allogeneic Cell Therapy Market, By Region, 2019-2027 (USD Million)

21 North America: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

22 North America: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

23 North America: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

24 North America: Allogeneic Cell Therapy Market, By Country, 2019-2027 (USD Million)

25 U.S: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

26 U.S: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

27 U.S: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

28 Canada: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

29 Canada: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

30 Canada: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

31 Mexico: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

32 Mexico: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

33 Mexico: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

34 Rest of North America: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

35 Rest of North America: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

36 Rest of North America: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

37 Europe: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

38 Europe: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

39 Europe: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

40 Europe: Allogeneic Cell Therapy Market, By Country, 2019-2027 (USD Million)

41 Germany: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

42 Germany: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

43 Germany: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

44 UK: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

45 UK: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

46 UK: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

47 France: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

48 France: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

49 France: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

50 Italy: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

51 Italy: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

52 Italy: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

53 Spain: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

54 Spain: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

55 Spain: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

56 Netherlands: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

57 Netherlands: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

58 Netherlands: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

59 Rest Of Europe: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

60 Rest Of Europe: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

61 Rest Of Europe: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

62 Asia Pacific: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

63 Asia Pacific: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

64 Asia Pacific: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

65 Asia Pacific: Allogeneic Cell Therapy Market, By Country, 2019-2027 (USD Million)

66 China: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

67 China: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

68 China: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

69 India: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

70 India: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

71 India: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

72 Japan: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

73 Japan: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

74 Japan: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

75 South Korea: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

76 South Korea: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

77 South Korea: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

78 Thailand: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

79 Thailand: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

80 Thailand: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

81 Indonesia: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

82 Indonesia: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

83 Indonesia: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

84 Malaysia: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

85 Malaysia: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

86 Malaysia: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

87 Singapore: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

88 Singapore: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

89 Singapore: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

90 Vietnam: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

91 Vietnam: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

92 Vietnam: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

93 Rest of APAC: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

94 Rest of APAC: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

95 Rest of APAC: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

96 Middle East & Africa: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

97 Middle East & Africa: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

98 Middle East & Africa: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

99 Middle East & Africa: Allogeneic Cell Therapy Market, By Country, 2019-2027 (USD Million)

100 Saudi Arabia: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

101 Saudi Arabia: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

102 Saudi Arabia: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

103 UAE: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

104 UAE: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

105 UAE: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

106 Israel: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

107 Israel: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

108 Israel: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

109 South Africa: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

110 South Africa: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

111 South Africa: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

112 Rest of MEA: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

113 Rest of MEA: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

114 Rest of MEA: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

115 Central & South America: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

116 Central & South America: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

117 Central & South America: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

118 Central & South America: Allogeneic Cell Therapy Market, By Country, 2019-2027 (USD Million)

119 Brazil: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

120 Brazil: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

121 Brazil: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

122 Chile: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

123 Chile: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

124 Chile: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

125 Argentina: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

126 Argentina: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

127 Argentina: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

128 Rest of CSA: Allogeneic Cell Therapy Market, By Indication, 2019-2027 (USD Million)

129 Rest of CSA: Allogeneic Cell Therapy Market, By End-User, 2019-2027 (USD Million)

130 Rest of CSA: Allogeneic Cell Therapy Market, By Type, 2019-2027 (USD Million)

131 Allogene Therapeutics: Products Offered

132 Century Therapeutics: Products Offered

133 Bristol Myers Squibb: Products Offered

134 Adaptimmune Ltd: Products Offered

135 Autolus: Products Offered

136 TrakCel: Products Offered

137 Sorrento Therapeutics: Products Offered

138 Tmunity Therapeutics: Products Offered

139 Bellicum Pharmaceuticals Inc.: Products Offered

140 Other Companies: Products Offered

141 Bluebird Inc.: Products Offered

List of Figures

1. Global Allogeneic Cell Therapy Market Segmentation & Research Scope

2. Primary Research Partners and Local Informers

3. Primary Research Process

4. Primary Research Approaches

5. Primary Research Responses

6. Global Allogeneic Cell Therapy Market: Penetration & Growth Prospect Mapping

7. Global Allogeneic Cell Therapy Market: Value Chain Analysis

8. Global Allogeneic Cell Therapy Market Drivers

9. Global Allogeneic Cell Therapy Market Restraints

10. Global Allogeneic Cell Therapy Market Opportunities

11. Global Allogeneic Cell Therapy Market Challenges

12. Key Allogeneic Cell Therapy Market Manufacturer Analysis

13. Global Allogeneic Cell Therapy Market: Porter’s Five Forces Analysis

14. PESTLE Analysis & Impact Analysis

15. Allogene Therapeutics: Company Snapshot

16. Allogene Therapeutics: Swot Analysis

17. Century Therapeutics: Company Snapshot

18. Century Therapeutics: Swot Analysis

19. Bristol Myers Squibb: Company Snapshot

20. Bristol Myers Squibb: Swot Analysis

21. Adaptimmune Ltd: Company Snapshot

22. Adaptimmune Ltd: Swot Analysis

23. Autolus: Company Snapshot

24. Autolus: Swot Analysis

25. Sorrento Therapeutics: Company Snapshot

26. Sorrento Therapeutics: Swot Analysis

27. Tmunity Therapeutics: Company Snapshot

28. Tmunity Therapeutics: Swot Analysis

29. Bellicum Pharmaceuticals Inc.: Company Snapshot

30. Bellicum Pharmaceuticals Inc.: Swot Analysis

31. TrakCel: Company Snapshot

32. TrakCel: Swot Analysis

33. Bluebird Inc.: Company Snapshot

34. Bluebird Inc.: Swot Analysis

35. Other Companies: Company Snapshot

36. Other Companies: SWOT Analysis

The Global Allogeneic Cell Therapy Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Allogeneic Cell Therapy Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

What is the projected market size of the global allogeneic cell therapy market?

The global allogeneic cell therapy market is projected to grow from USD 994.9 million in 2022 to USD 1,570.1 million in 2027 at a CAGR of 9.6% from 2022 to 2027.

Who are the major vendors in the allogeneic cell therapy market?

Allogene Therapeutics, Century Therapeutics, Bristol Myers Squibb, Adaptimmune Ltd, Autolus., TrakCel, Tmunity Therapeutics, Bellicum Pharmaceuticals Inc., Sorrento Therapeutics, Bluebird Inc., Minerva Biotechnologies Corporation, Kite Pharma, Celgene Corporation, Cellectis, Fortress Biotech., Promab Biotechnologies, Immune Therapeutics, Ziopharm Oncology Inc., Juno Therapeutics, Novartis AG, Celyad, Eureka Therapeutics Inc., TILT Biotherapeutics, and Poseida Therapeutics Inc., among others, are the some of the key players in the allogeneic cell therapy market.

What is the Covid-19 impact on future allogeneic cell therapy providers?

The COVID-19 epidemic has increased sales for a number of pharmaceutical and biotechnology firms. The outbreak has caused the healthcare sector as a whole to grow significantly, albeit other areas, including oncology, have had to take a backseat as the globe focuses on reducing the pandemics effects. Increasing investment in vaccine development and novel therapeutic methods have increased the demand for the application of stem cells, gene therapy, and T cell-based treatments for COVID-19 applications are expected to result in the rapid growth of the allogeneic cell therapy market

What are the major drivers in the allogeneic cell therapy market?

Which region is expected to dominate the allogeneic cell therapy market?

Growing investment in the cell, gene, and tissue therapies has been a key factor in the markets growth in North America. The North American allogeneic cell therapy market is anticipated to be dominated by the United States. The demand for advanced therapy pharmaceuticals is anticipated to rise as a result of the increasing number of FDA approvals for gene therapy and stem cell therapy treatment methods.